INDUSTRY EXPERT ARTICLES

The integration of hybrid AI into the drug development process represents a transformative shift that will not only accelerate the discovery of new therapies but also enhance their precision and safety.

Organizations must adopt a proactive defense strategy to stay ahead, which isn’t always easy to do with human capabilities that are limited. Fortunately, artificial intelligence can act as an auxiliary defense force and play a key role in helping improve cybersecurity efforts in a number of ways, responding faster than human teams alone.

Chuck Papageorgiou writes: “With no effective prevention or long-term treatment, receiving a diagnosis of Alzheimer’s disease can seem like a fate worse than death for patients and their families and caregivers. However, a wave of innovation is bringing new hope to the 7 million Americans already living with Alzheimer’s disease and the 500,000 who will receive this devastating diagnosis each year.”

“The way we think about healthcare is evolving rapidly. From AI-assisted diagnostics to telehealth expansion, technology is breaking down barriers and reshaping how people access essential medical services. In eyecare, artificial intelligence is increasingly redefining accessibility, affordability, and accuracy in vision care,” writes Matthias Hofmann.

While virtual reality in telehealth might seem like a novel technology to incorporate into healthcare, at least one portion of our field has been using it for 250 years. Simulation technology has long been instrumental in medical training since it makes failure safe while students practice key skills.

According to recent research, 15% of the global population over the age of 30 is affected by osteoarthritis, or OA, the most common form of arthritis. This same study projects that OA will affect nearly 1 billion people by the year 2050. These statistics show that OA is a pressing medical concern that should be a top priority for medical professionals seeking to improve their patients’ quality of life.